Pay-to-Play Provision: What It Is, Who Gets Hurt, and What Founders Can Do About It

The Short Version First

A pay-to-play provision is a clause in a venture capital term sheet that says: invest in this next round, or lose your preferred stock rights.

That is the whole idea. You either pay (invest again) or you stop playing (lose your protections).

Investors who skip the round get their preferred shares converted to common stock. That wipes out their liquidation preference, their anti-dilution protection, and often their board seat. Everything they negotiated in the original deal is gone.

It sounds aggressive. It is. That is the point.

But it is also one of the most misunderstood clauses in startup finance. I've watched founders see it on a term sheet and panic. I've watched investors see it and get angry. Neither reaction helps anyone figure out what to do about it.

This article explains what pay-to-play provisions do, when they show up, how common they are, and the specific moves available to both founders and investors when one lands on the table.

What a Pay-to-Play Provision Does

The mechanics are simpler than the jargon suggests.

When a company raises a new round, the pay-to-play provision requires each existing preferred investor to buy their pro-rata share of the new round. Pro-rata means proportional to their current ownership stake. If you own 10% of the company, you have to fund 10% of the new round.

If you do fund your share, nothing changes. You keep your preferred stock rights. You keep your liquidation preference, anti-dilution protection, and all your other protections.

If you skip the round, the penalty kicks in. The two most common penalties are:

Full conversion to common stock. Your preferred shares convert to common shares, usually on a 1:1 basis. You lose your place in the liquidation waterfall. You lose your anti-dilution rights. In some cases, you lose your board seat and your information rights. You become an ordinary shareholder.

Conversion to shadow preferred. A softer version. Your shares convert to a new series of preferred stock that keeps some basic economic rights but strips out the protective provisions - no anti-dilution, no veto rights, no board representation. You stay ahead of common shareholders but well behind the new investors.

Which penalty applies depends entirely on how the provision is drafted. Some are mild. Some are severe. Some use a punitive conversion ratio - for example, 10 shares of preferred convert to just 1 share of common. That wipes out a significant portion of the non-participating investor's ownership outright.

According to a study published via the Columbia Law School Blue Sky Blog, which analyzed 150 pay-to-play provisions hand-collected from U.S. startup charters, the penalty aspect varies considerably across deals. The research found that provisions differ not only in whether shares convert to common or shadow preferred, but also in whether that conversion applies to the investor's entire holdings and whether a punitive conversion ratio is applied.

Why Companies Use Them

Pay-to-play provisions solve a specific problem: the free-rider.

Here is how that problem develops. An investor leads your Series A. They negotiate strong preferred stock terms - liquidation preference, anti-dilution protection, the works. A few years later, you are raising a down round. The company's valuation has dropped. The new investors want clean terms. But your Series A investor decides to sit out. They do not invest a dollar. They just wait.

Without a pay-to-play provision, that investor keeps all their Series A protections. They keep their liquidation preference from the old round. Their stack grows relative to the company's current value. New investors look at the cap table and see a bloated preference stack sitting above them. They either walk or demand harsher terms to compensate.

With a pay-to-play provision, that investor must choose: write a check or lose the protections you negotiated. The provision forces a clean decision: you believe in the company enough to fund it again, or your economics reset to reflect your reduced commitment.

That is the legitimate case for pay-to-play. It keeps the cap table workable. It prevents investors from enjoying upside they did not earn by helping the company through a rough patch.

The ECGI research paper on pay-to-play financing frames it precisely this way: the provisions allow startups to proceed with smaller initial investments by assuring entrepreneurs that investors have stronger incentives to maintain support in future rounds. That feature is what made pay-to-play particularly useful in life sciences, where information gaps between entrepreneurs and investors are extreme and initial investment amounts are hard to agree on.

When They Show Up: Numbers

Pay-to-play provisions are not random. They follow a clear pattern tied to market conditions.

The Cooley venture financing report - one of the most comprehensive data sources on VC deal terms - tracks pay-to-play prevalence across hundreds of deals per quarter. The pattern is stark.

During the bull market of the early part of this decade, pay-to-play provisions were nearly invisible. Companies could raise easily. Investors competed for allocations. Nobody needed to force commitment. Pay-to-play sat unused.

Then the market tightened. Valuations fell. Down rounds became common. And pay-to-play came back hard.

According to Cooley's quarterly reports, the percentage of deals including a pay-to-play provision climbed from 5.7% in Q1 of one recent tracking period to 7.1% by Q3, then to 8% the following Q1, hitting 8.7% by Q2 of the next year. That was the highest level since Cooley began tracking this metric. The number climbed further to 9.2% by Q4, and then to 10.1% by the most recent Q2 in the dataset. Cooley noted that Q3 and Q4 were only the third time in the report's history that this figure exceeded 8%.

That may sound small. But consider the baseline: pay-to-play provisions were historically rare in technology deals. Breaking 8% marks a structural shift in how deals are being put together.

And the trend has a clear pattern. In tighter market conditions, pay-to-play provisions become roughly twice as likely to appear in funding agreements, as companies face reduced cash flow and more limited access to capital.

Down rounds are the primary trigger. According to the same Cooley data, down rounds reached 32% of deals at peak - the highest in the report's history going back to 2014. That level of valuation pressure pushes companies toward whatever tools can secure committed capital. Pay-to-play is one of those tools.

The Sequoia-Citizen Case: What Happens When a Major Investor Walks

Sequoia's decision to walk away from Citizen is the clearest recent example of a pay-to-play provision forcing a major investor's hand.

Citizen is a crime-tracking app that had raised over $133 million from investors including Greycroft, 8VC, Lux Capital, and Sequoia Capital. Sequoia led the Series A, putting partner Mike Vernal on the board.

When Citizen needed fresh capital and could not attract new outside investors on favorable terms, its management approached existing investors with a pay-to-play deal. The structure would have required investors to participate in a new recapitalization round or face severe dilution of their existing stake.

Sequoia declined. Vernal resigned from the board. The deal would have virtually wiped out Sequoia's investment if they had stayed without reinvesting. By walking away entirely, they accepted the loss rather than put more money into a company they no longer believed in.

One person close to Citizen called the decision ruthless, arguing that as Citizen's earliest and most significant backer, Sequoia had an obligation to support the company. Others in Silicon Valley saw it differently: Sequoia works for its limited partners - universities, pensions, charities - and continuing to fund a struggling company would have meant misallocating their capital.

Citizen did raise the money it needed from other backers. But the situation illustrated the exact dynamic pay-to-play provisions create: they force a binary decision. Commit or get out.

For founders, the lesson is double-edged. Pay-to-play provisions can secure capital from investors who remain committed. But they can also push out investors who have lost conviction - and those departures signal to the market, which creates its own problems.

Life Sciences vs. Tech: A Completely Different Reality

The Holloway Guide to Raising Venture Capital makes a point I keep coming back to: pay-to-play provisions are extremely rare in technology investment deals, but absolutely common in biotechnology and life sciences deals.

The reason is structural. Biotech and life sciences companies require enormous amounts of capital over long timeframes just to get a product to market. Early investors know from day one that they will be asked to fund multiple subsequent rounds. Pay-to-play provisions are built into the deal architecture as a way of making explicit what is already implicit: if you invest in this company, you are committing to go the distance.

The NVCA recently updated its model equity financing documents specifically to address the life sciences context. The update includes language temporarily suspending a preferred stockholder's right to convert during the period before a financing round with a pay-to-play component closes. This matters in tranched financings, where investors must fund subsequent tranches when the company hits clinical milestones - otherwise, they face conversion at punitive ratios.

Life sciences financings are frequently structured in tranches tied to milestones like clinical trial initiation or trial readouts. In that context, pay-to-play provisions do not signal distress - they are just how the financing architecture works. An investor who signs up for a biotech deal is signing up for a multi-year commitment with built-in reinvestment obligations.

Tech founders who see a pay-to-play provision on a term sheet should treat it very differently than a biotech founder who sees the same clause. In tech, it is usually a signal of trouble. In life sciences, it is often just standard deal mechanics.

The Three Levels of Pay-to-Play Severity

Pay-to-play provisions range from relatively mild to existentially punitive. Knowing the difference matters before you sign.

Soft pay-to-play. The investor loses pro-rata rights in future rounds if they do not participate. They keep their preferred stock but lose the ability to maintain their ownership percentage going forward. This is the least bad version - it affects future flexibility more than current economics.

Medium pay-to-play. The investor loses specific protective provisions tied to their series. This can include anti-dilution protection, information rights, and certain voting rights. Their preferred shares stay as preferred, but with less power behind them.

Hard pay-to-play. The investor's preferred shares convert to common stock if they do not invest. This is called a forced conversion. They lose their place in the liquidation waterfall, their anti-dilution protection, their board seat, and their voting rights as preferred holders. In some cases, the conversion ratio is punitive - receiving one share of common for every ten shares of preferred.

According to the Morrison Foerster analysis of NVCA model documents, the standard scenario involves preferred stock converting to common stock on a 1:1 basis. That ratio can be negotiated, but the whole point is to wipe out the preferred. Any ratio harsher than 1:1 requires extra scrutiny.

One critical legal point: from a Delaware corporate law standpoint, pay-to-play provisions face greater scrutiny when investors in the same stock class are treated differently. Delaware courts have suggested that provisions applying equally to all investors are more likely to be upheld than provisions that discriminate based on ownership thresholds or other characteristics. The Columbia Law research found that many provisions do discriminate among investors - applying to Major Investors above a certain ownership threshold but not to smaller holders. That creates legal risk the charter drafters do not always flag.

The Cram-Down Structure: What It Looks Like in Practice

The most aggressive pay-to-play scenario is often called a cram-down. Understanding the full sequence helps founders know what they are agreeing to.

Here is how Fenwick and West described a real-world example for a company they called Tough Times Inc.:

Step one: All existing preferred stock converts to common stock at 1:1. The preferred stack is wiped out. All existing investors are now common shareholders.

Step two: A new lead investor prices a new preferred round at roughly 25% of the last round's valuation. This is a steep down round. The new preferred sits at the top of the cap table.

Step three: A rights offering goes to all existing shareholders (who are now holding common after the conversion). Those who invest at their pro-rata share get pulled up - their common stock converts back into a new series of preferred that sits just below the new money preferred in the waterfall.

Step four: Those who do not participate stay as common shareholders. They have lost all their preferred protections permanently.

The pulled-up preferred typically carries a liquidation preference of roughly 25% of the prior preference - negotiated, but a significant haircut. It represents the same number of shares as before the conversion, depending on the ratio at which preferred was converted to common.

Fenwick noted that the level of participation required to trigger the pull-up starts at full pro-rata. And the new lead investor often backstops the rights offering, guaranteeing the company raises a minimum amount. That backstop is valuable for the company - it provides certainty - but it is not always available.

This structure appears aggressive because it is. The goal is to clean up a cap table that has become unworkable, reset preferences to a level new investors can accept, and force existing investors to declare whether they are in or out.

What the Numbers Behind 150 Real Provisions Show

The most rigorous empirical research on pay-to-play provisions was published via the Columbia Law School Blue Sky Blog and ECGI. The researcher analyzed 150 pay-to-play provisions hand-collected from U.S. startup charters.

The findings challenge several assumptions that practitioners tend to hold.

First: only slightly more than half of pay-to-play clauses in the dataset targeted down-round financings. That means a significant portion are used in flat rounds or even up rounds - situations where the conventional wisdom says pay-to-play should not be needed.

Second: many provisions discriminate among investors based on ownership thresholds or other characteristics. This creates legal risk, since Delaware courts have indicated they are more likely to uphold clauses that apply equally to all investors.

Third: startup boards are often given the power to trigger or disarm the clauses at their discretion, regardless of investor consent. This is significant. The board - which may include directors whose interests conflict with the company's - can choose when and whether the pay-to-play kicks in. That governance angle is rarely discussed in the standard explanations of how these provisions work.

The same research notes a trend toward what it calls stealth governance - lawyers using functionally equivalent mechanisms outside the charter when legal risks seem high. This reduces transparency and makes it harder for startup stakeholders to understand what these mechanisms do.

What Founders Should Know Before Agreeing to One

Pay-to-play provisions are not automatically bad for founders. In the right situation, they are genuinely useful. But founders need to go in with eyes open.

They are usually not in a Series A term sheet. Analysis of pay-to-play provisions across the VC market makes clear that these provisions typically do not appear in Series A term sheets. By the time you are in a down round, it is usually the lead investor introducing the pay-to-play, not the founder asking for it.

Carve-outs are non-negotiable. Angel investors and strategic investors are often unable to participate in follow-on rounds. If your cap table includes angels or strategics, you need carve-outs written explicitly into the pay-to-play provision. Without them, those investors face conversion even though they never intended to participate in later rounds. That is both unfair and, in some cases, legally vulnerable.

Common shareholders get hurt too. Pay-to-play provisions often happen alongside down rounds. The combination is particularly damaging for founders and employees holding common stock. The down-round repricing reduces the value of common shares. The pay-to-play conversion - which forces some preferred into common - increases the number of common shares outstanding, diluting everyone who already holds common. Founders need to model this specific scenario before agreeing to a pay-to-play structure.

The cap table gets cleaned, but relationships do not. One of the arguments for pay-to-play is that it produces a cleaner cap table by removing investors who no longer want to support the company. That is true. As Kruze Consulting's team puts it, pay-to-play will not encourage friendly relations between VCs. Investors who have been in a company for five to eight years, finally seeing progress, can feel betrayed when a pay-to-play provision washes them out because they do not have reserves left.

Consider alternatives first. As practitioners at law firms advising on down rounds consistently note: before agreeing to a pay-to-play provision in a down round, the company should undertake a careful review of alternative financing strategies with experienced legal and financial advisers. Bridge financing, convertible notes, SAFE extensions, and clean preferred rounds are all worth exhausting before reaching for the pay-to-play tool.

What Investors Should Know When They See One

If you are an existing investor who just received a term sheet with a pay-to-play provision, your first move is to read it slowly and identify the exact penalty structure.

Is this a soft pay-to-play that strips future rights? A medium version that removes anti-dilution protection? Or a hard version that forces your preferred into common if you do not write a check?

Once you know the penalty, your decision framework is simple: do you believe in the company's long-term prospects enough to invest again at the current terms?

If yes, participate. Maintain your preferred rights. You stay in the game.

If no, accept the conversion. You will become a common shareholder. Your liquidation preference disappears. But you are not obligated to put more capital into something you have lost conviction on.

If you are uncertain, push back on the terms - specifically the severity of the penalty - or negotiate a carve-out if you are a smaller fund that genuinely cannot afford to participate at full pro-rata.

Pay-to-play provisions are perceived by existing investors as aggressive, according to Morrison Foerster's analysis, and must be administered with care. Some VCs only invest in early-stage rounds - it is simply not their mandate to participate in later rounds. Implementing a pay-to-play without acknowledging that reality can alienate investors who are willing to support the company in other ways but cannot write checks in subsequent rounds.

The AngelList Education Center puts it clearly: deciding whether to participate in a pay-to-play round depends on your outlook on the company. An investor who is bullish on the long-term potential will participate. One who has cooled on the business may choose to pass and incur the consequences. There is no obligation to continue investing - only a consequence if you do not.

The Milestone-Linked Alternative

One evolution worth watching: milestone-linked pay-to-play provisions.

Some startups are coupling pay-to-play triggers with milestone provisions. Instead of requiring investors to fund an arbitrary new round on the company's timeline, the obligation to invest is tied to specific achievements - a revenue target, a product launch, a regulatory milestone.

It protects the company's equity structure while maintaining investor confidence. Dilution only occurs when measurable progress has been made. Investors know what they are committing to and can model the outcome.

In the life sciences context, this is already standard. Clinical trial milestones gate each tranche of funding. Investors know the structure from day one. The pay-to-play provision is part of a planned financing architecture, not a crisis response.

Tech startups are beginning to adopt similar structures. The advantage for founders is that it reframes the pay-to-play as a reward mechanism rather than a punishment mechanism. Investors who do not participate at milestone A are not failing the company - they are declining to fund a specific stage that the company has clearly defined.

How Pay-to-Play Interacts With Anti-Dilution Protection

The relationship between pay-to-play and anti-dilution provisions is one of the most misunderstood areas of VC term sheets.

Anti-dilution protection adjusts an investor's conversion price if the company later raises at a lower valuation. The two most common forms are full-ratchet (aggressive, adjusts all the way to the new lower price) and weighted average (more moderate, adjusts based on how many shares were issued at the lower price).

Pay-to-play provisions work together with anti-dilution provisions. When a pay-to-play is in effect, if an investor does not participate in a subsequent round, the anti-dilution provision no longer applies to them. They lose that protection.

That creates a direct incentive to participate. The investor wants to keep their anti-dilution protection. The only way to keep it is to write a check. The pay-to-play makes passive free-riding expensive.

From the founder's perspective, this is useful. Investors who push back hard on pay-to-play provisions while simultaneously demanding full-ratchet anti-dilution protection are signaling something important about how they view their relationship with the company. A full-ratchet anti-dilution without any pay-to-play obligation means the investor gets maximum protection whether or not they continue supporting the company. That is a one-sided deal that should be negotiated hard.

Cooley's data points to an interesting development: in one recent quarter, for the first time since they began reporting, 100% of reported deals had broad-based weighted-average anti-dilution protection. No deals had full-ratchet anti-dilution. That is a sign that founders have successfully pushed back on the most aggressive anti-dilution structures - even as pay-to-play provisions have risen to record highs.

Negotiating a Pay-to-Play Provision: Specific Moves

If you are a founder facing a pay-to-play provision in a proposed term sheet, here are the specific points to negotiate.

Conversion type. Push for shadow preferred over full common conversion if you can get it. Shadow preferred retains basic economic rights and strips protective provisions. It is less severe for the non-participating investor and reduces the legal risk of challenged provisions.

Conversion ratio. The standard is 1:1 (one share of preferred converts to one share of common). If the term sheet proposes a punitive ratio like 10:1, push back hard. Punitive ratios are more legally vulnerable and are often unnecessary to achieve the alignment goal.

Carve-outs. Negotiate explicit carve-outs for angels, strategic investors, and any early-stage funds whose mandate does not include follow-on rounds. Get these in writing in the term sheet, not just verbal agreement.

Full vs. partial pro-rata. Some provisions require investors to fund 100% of their pro-rata share to avoid conversion. Others allow partial participation - funding 75% or 50% of pro-rata still counts as participating. Partial-participation thresholds are more achievable for investors with capital constraints and reduce the chance of inadvertent conversions.

Trigger rounds. Does the provision apply to every future round, or only down rounds? A provision that applies to all future rounds is much more aggressive than one limited to below-price financings. Limiting the trigger to down rounds is both fair and sufficient.

Sunset clause. Some pay-to-play provisions have a time limit. After a defined period - say, 24 months - the provision expires. This reduces the long-tail obligation on investors and makes the provision more palatable in negotiation.

Board discretion. The research findings about board power to trigger or disarm pay-to-play provisions are worth understanding. If the board has unilateral power to activate the provision, that is significant governance authority. Founders should understand who sits on the board and whether that discretion creates conflicts of interest.

Who Benefits From Pay-to-Play Provisions

Pay-to-play provisions primarily benefit the company and the investors who participate.

The company benefits because it gets a cleaner cap table, fewer passive investors sitting on preference stacks, and more certainty that its investor base is genuinely committed.

Participating investors benefit because the conversion of non-participating preferred to common or shadow preferred reduces the preference overhang above new money. It makes the cap table more attractive to the next round of investors. It also concentrates ownership among the investors who are most committed - which, if the company succeeds, increases their returns.

Non-participating investors lose. They built their position, negotiated their protections, and now face conversion because they cannot or will not fund the next round. Small funds that are out of capital, early-stage funds that do not invest in later rounds by mandate - and angel investors who cannot write six-figure checks - all face this outcome.

Founders are in the middle. Pay-to-play can secure the capital they need. But it can also accelerate the exit of investors who might have provided valuable advice, introductions, or other non-capital support. And it directly hurts common shareholders - including founders themselves - through the dilution mechanics of a down round combined with a pay-to-play restructuring.

Pay-to-play is a crisis tool. It exists because something has already gone wrong. Managing investor relations, extending runway, and maintaining realistic communication with your cap table long before a down round becomes inevitable is the work that matters.

What This Looks Like in the Context of Fundraising Strategy

Pay-to-play provisions do not exist in a vacuum. They are one piece of a larger fundraising picture that includes down rounds, recapitalizations, bridge financing, and the ongoing management of investor relationships.

Founders who understand pay-to-play provisions before they need them are in a much stronger negotiating position than those encountering the term for the first time in a crisis. Knowing the structure, knowing what is negotiable, and knowing what carve-outs to ask for can save significant equity and maintain key relationships through a difficult round.

The most important preparation is having investors in your cap table who are genuinely prepared to support you through multiple rounds. That starts at the term sheet stage - not when you are staring down a recapitalization. Selecting investors based on their track record of supporting portfolio companies through difficult rounds, their fund size and reserve policy, and their mandate (early-stage only vs. multi-stage) is foundational.

Finding the right investors starts with knowing who they are before you pitch. Tools like ScraperCity let founders search millions of contacts by title, industry, and company size - useful for mapping out the investor universe before you start outreach, so you are talking to funds whose mandate fits your stage and sector.

But the most valuable preparation is education. Understanding the provisions in your own term sheets - including pay-to-play clauses - before you sign them is table stakes. And if you are working through a complex down round or recapitalization, working with advisers who have been through these situations before can save more equity than any negotiation tactic.

The Plain-English Summary

Pay-to-play provisions require existing investors to invest in the next round or lose their preferred stock rights.

They show up most often in down rounds, when companies need capital and investors are hesitant. They are standard in biotech and life sciences, where multi-round funding commitments are built into the deal architecture from the start. They are increasingly common in tech when market conditions tighten.

The penalty for not participating ranges from losing pro-rata rights (soft) to losing all preferred stock protections and converting to common (hard).

Cooley's venture financing reports show pay-to-play provisions rising from historical levels around 5% of deals to above 10% as market conditions have tightened - the highest levels since tracking began in 2014.

For founders, the provisions can be useful tools to secure committed capital and clean up a cap table. But they require careful negotiation - carve-outs for investors who cannot participate by mandate, clear conversion ratios, defined trigger rounds, and protections for common shareholders who get caught in the crossfire.

For investors, the provisions force a binary decision: believe in the company enough to write another check, or accept conversion and move on. There is no comfortable middle ground.

The Sequoia-Citizen situation showed what happens when a major investor declines. They walked. The company survived. But the signal it sent - that even a blue-chip backer had lost conviction - shaped how the market viewed that company for years afterward.

Pay-to-play provisions are signals in both directions. For a company, issuing one signals financial stress. For an investor who participates, it signals genuine conviction. For an investor who walks, it signals a verdict on the company's prospects.

Reading what signal you are sending - and what signal you are receiving - is the skill.